Biotech

All Articles

AstraZeneca, Daiichi unpack Dato-DXd's overall survival fail

.AstraZeneca and also Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually neg...

Roivant introduces new 'vant' to advance Bayer high blood pressure med

.Matt Gline is back with a brand-new 'vant' business, after the Roivant Sciences CEO paid for Bayer ...

Viridian eye condition phase 3 smash hits, advancing push to rivalrous Amgen

.Viridian Therapies' phase 3 thyroid eye disease (TED) medical test has actually attacked its own pr...

Bain reveals $3B fund permanently science firms

.Along with a powerful performance history for recognizing diamonds in the rough, Bain Funds Life Sc...

Genentech's cancer restructure created 'for scientific reasons'

.The current decision to merge Genentech's two cancer cells divisions was actually produced "scienti...

Tern oral GLP-1 presents 5% fat burning at 1 month at greatest dosage

.Terns Pharmaceuticals' selection to fall its own liver condition passions might yet pay, after the ...

Merck, Daiichi regular early excellence in tiny mobile lung cancer cells along with updated ADC data

.Merck &amp Co.'s long-running attempt to land a hit on tiny cell lung cancer cells (SCLC) has acqui...

Boehringer, Bayer innovation bronchi cancer cells medicines towards Astra struggle

.Some individuals with non-small cell lung cancer cells (NSCLC) have anomalies in a genetics named h...

MBX aims for $136M IPO to take competitor to Ascendis into stage 3

.MBX has elaborated strategies to consume over $136 thousand from its IPO as the biotech aims to bri...

Relay bust cancer cells data tee up encounter AstraZeneca's Truqap

.Relay Therapeutics has actually beaten its own survival objective in a first-in-human breast cancer...